Medifast, Inc.
MED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,091 | $99,415 | $143,568 | $164,031 |
| Dep. & Amort. | $17,400 | $13,107 | $10,980 | $6,812 |
| Deferred Tax | -$7,403 | $1,211 | -$924 | -$3,715 |
| Stock-Based Comp. | $7,363 | $8,188 | $11,053 | $9,903 |
| Change in WC | -$9,745 | $20,276 | $21,651 | -$87,646 |
| Other Non-Cash | $14,770 | $5,460 | $8,242 | $5,160 |
| Operating Cash Flow | $24,476 | $147,657 | $194,570 | $94,545 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,454 | -$6,483 | -$16,681 | -$34,209 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$46,595 | -$54,564 | $0 | $0 |
| Inv. Sales/Matur. | $27,434 | $0 | $5,267 | $5,145 |
| Other Inv. Act. | $95 | $0 | $0 | $0 |
| Investing Cash Flow | -$26,520 | -$61,047 | -$11,414 | -$29,064 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$836 | -$6,960 | -$127,961 | -$62,088 |
| Dividends Paid | -$715 | -$73,017 | -$71,620 | -$63,856 |
| Other Fin. Act. | $36 | $188 | $0 | $811 |
| Financing Cash Flow | -$1,515 | -$79,789 | -$199,581 | -$125,133 |
| Forex Effect | $47 | -$72 | -$67 | $112 |
| Net Chg. in Cash | -$3,512 | $6,749 | -$16,492 | -$59,540 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94,440 | $87,691 | $104,183 | $163,723 |
| End Cash | $90,928 | $94,440 | $87,691 | $104,183 |
| Free Cash Flow | $17,022 | $141,174 | $177,889 | $60,336 |